Carfilzomib
20S Proteasome inhibitor
Product Specifications
Background
Carfilzomib / PR-17 is an irreversible proteasome inhibitor that targets the chymotrypsin-like beta5 subunit of 20S proteasome. It can arrest the cell cycle and trigger apoptosis in tumor cell lines.
CAS Number
868540-17-4
Product Name Alternative
(αS) -α-[[2- (4-morpholinyl) acetyl]amino]benzenebutanoyl-L-leucyl-N-[ (1S) -3-methyl-1-[[ (2R) -2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide, PR-17, Carfilzomib, Kyprolis, Carfilzomib (PR-171), PR-171, UNII-72X6E3J5AR
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Cancer | Cancer Growth Inhibitors | Proteasome Inhibitors
Purity
>98% (TLC) ; NMR (Conforms)
Weight
0.025
Format
White powder
Solubility
Soluble in DMSO (80 mg/ml), or ethanol (25 mg/ml)
Molecular Formula
C40H57N5O7
Molecular Weight
719.9
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471429-100 1x 100 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740040-500 1x 500 µL
CD35 / CR1 (E11), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470226-100 1x 100 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 